Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease.
Chonat S, Graciaa S, Shin HS, Newton JG, Quarmyne MO, Boudreaux J, Tang A, Zerra PE, Rollins MR, Josephson CD, Brown C, Joiner CH, Fasano RM, Stowell SR.
Chonat S, et al. Among authors: quarmyne mo.
Haematologica. 2020 Dec 1;105(12):2887-2891. doi: 10.3324/haematol.2020.262006.
Haematologica. 2020.
PMID: 33256394
Free PMC article.
No abstract available.